Summary
Here we present refined surgical procedures on successfully performing intraportal islet transplantation, a clinically relevant but technically challenging surgical procedure, in mice.
Abstract
Although the liver is currently accepted as the primary transplantation site for human islets in clinical settings, islets are transplanted under the kidney capsule in most rodent preclinical islet transplantation studies. This model is commonly used because murine intrahepatic islet transplantation is technically challenging, and a high percentage of mice could die from surgical complications, especially bleeding from the injection site post-transplantation. In this study, two procedures that can minimize the incidence of post-infusion portal vein bleeding are demonstrated. The first method applies an absorbable hemostatic gelatin sponge to the injection site, and the second method involves penetrating the islet injection needle through the fat tissue first and then into the portal vein by using the fat tissue as a physical barrier to stop bleeding. Both methods could effectively prevent bleeding-induced mouse death. The whole liver section showing islet distribution and evidence of islet thrombosis post-transplantation, a typical feature for intrahepatic islet transplantation, were presented. These improved protocols refine the intrahepatic islet transplantation procedures and may help laboratories set up the procedure to study islet survival and function in pre-clinical settings.
Introduction
Intraportal islet transplantation (IIT) via the portal vein is the most commonly used method for human islet transplantation in clinical settings. The mouse IIT model offers a great opportunity to study islet transplantation and test promising interventional approaches that can enhance the efficacy of islet transplantation1. IIT was first described in the 1970s and used by several groups1,2,3,4,5. It regained popularity after the breakthrough in human islet transplantation in the year 20006,7. However, most islet transplant studies used the kidney capsule as a preferred site for experimental islet transplantation due to its easy success. On the contrary, IIT is more technically challenging and less frequently used for islet transplantation studies8,9. Unlike IIT, however, islets transplanted under the kidney capsule do not suffer from the immediate blood-mediated inflammatory reaction characterized by thrombosis, inflammation, and hepatic tissue ischemia, and thus have better function than islets transplanted into the liver. The kidney capsule model, therefore, may not fully mimic the stresses encountered by islets in human islet transplantation10,11,12.
One of the major complications of IIT in mice is bleeding from the injection site after transplantation, which could cause 10-30% of mortality among different mouse strains12. In this paper, two refined approaches have been developed to stop bleeding more rapidly and securely and to reduce mouse mortality after an IIT. Visual demonstration of these refined details will help researchers identify the key steps of this technically challenging procedure. In addition, the location of the islet grafts in the recipient’s liver was determined by histological examination of the Hematoxylin and Eosin (H&E) stained liver tissue (whole section) bearing transplanted islets.
Subscription Required. Please recommend JoVE to your librarian.
Protocol
All procedures were conducted with the approval of the Institutional Animal Care and Use Committees at the Medical University of South Carolina and the Ralph H Johnson Medical Center in Charleston.
1. Diabetes induction using streptozotocin (STZ)
- Recipient mice preparation:
- Weigh all mice individually.
- Check blood glucose levels from a tail vein blood sample using a glucometer.
- STZ dose determination for three different scenarios:
- For mice with fatty liver disease inject one dose of STZ [40 mg/kg/day, intraperitoneal (i.p.) injection] for 5 consecutive days.
- For NOD-SCID mice inject 125 mg/kg of STZ, single injection, i.p. after overnight fasting.
- For C57BL/6 mice inject 225 mg/kg of STZ, single injection, i.p.
- Calculations for STZ (13.5 mg/mL):
NOTE: This calculation is for five C57BL/6 mice with body weights of 30 g:- Total body weights: 5 mice x 30 g/mouse = 150g
- STZ needed: 150 g x 225 mg/1000g STZ = 33.75 mg
- STZ preparation:
- Weigh the STZ following the pre-calculated dose.
- Transfer the weighed STZ powder into a 10 mL beaker on ice.
- Add 3 mL of sodium citrate solution to the beaker to dissolve the STZ.
- Mix well, filter sterilize through a 0.22-μm pore, and use the STZ solution within 10 min of preparation.
- STZ injection:
- Load the desired amount of STZ solution (enough for one mouse) into 1 mL syringe.
- Perform intraperitoneal injection at the lower right quadrant of mouse abdomen.
- Observe mice for 5 min after injection and check for any signs of discomfort during this period of time before putting them back into the cages.
- Monitor blood glucose level from a tail vein blood sample using a glucometer daily after the STZ injection.
NOTE: In this experiment, mice are considered diabetic when non-fasting blood glucose is > 350 mg/dL for two consecutive days.
2. Islet preparation
NOTE: Human islets were cultured in CMRL-1066 media supplemented with 10% fetal bovine serum (FBS), and 1% penicillin/streptomycin (P/S) at a density of 10,000 islet equivalent number (IEQ) per 100 mm cell culture dish9. Mouse islets were cultured in DMEM with 10% FBS and 1% P/S with the same density13. Male NOD-SCID and C57BL/7 mice between 6-10 weeks of ages were obtained from commercial sources.
- Detach cultured islets from cell culture dish by gentle scratching.
- Hand-pick desired numbers of islets (e.g., 300-350 islets) using a 1cc syringe and put them into sterile 1.5 mL microcentrifuge tubes on ice.
- Spin the tube for 10 seconds using the microcentrifuge.
- Remove the supernatant, leaving some liquid to avoid losing the pellet.
- Resuspend the pellet in 200 μL of HBSS with 0.5% bovine serum albumin (BSA).
- Aspirate the resuspended islets into a 0.5 mL insulin syringe.
- Place the syringe in the upright position. Let the islets sink down for 1 min.
- Push the syringe to remove all the bubbles, leaving about 100-150 μL of liquid containing islets.
- Place syringe head down and gently tap the side of the syringe to let the islets equally distribute throughout the liquid. Islets are now ready for injection.
3. Islet transplantation
- Induce and maintain the mouse under general anesthesia with 2% isoflurane. Check for the lack of pedal reflexes to ensure proper anesthetization of the animal.
- Shave and remove the fur in the abdomen area of the mouse.
- Administer a single pre-operative dose of Buprenorphine (0.1 mg/kg i.p.).
- Disinfect the surgical area with three alternating wipes of 2% iodine and 75% alcohol.
- Perform a laparotomy with micro scissors to generate a 1-1.5 cm incision.
- Open the peritoneal cavity with a retractor. Follow with either method A or method B as detailed below.
4. Method A: (stop bleeding with gel foam, Figure 1A)14,15,16
- Mouse preparation
- Place a sterile gauze around the incision.
- Gently pull out the intestine using a forceps and keep it on the gauze.
- Identify the portal vein by its location and expose it well.
- Cover the intestine with a warm saline-wet gauze during the entire surgery.
- Insert the islet preloaded insulin syringe needle through the portal vein near the duodenum (Figure 1B). To do so, hold the needle with the hole (bevel) facing down and position the opening surface's angle parallel to the portal vein wall before penetrating through the wall.
- Pull the plunger to draw some blood (20-50 μL) into the syringe to mix the islets first.
- Infuse the islets into the portal vein slowly while repeatedly pulling and pushing the plunge.
- Place a piece of gel foam (about 0.5 cm x 0.5 cm in size) to cover the injection site.
- Press the gel foam down with a cotton tip while pulling out the needle from the portal vein.
- Continue pressing on the gel for about 2 min to confirm there is no active bleeding.
- Rollover the cotton tip over and away from the gel foam to make sure the gel foam covers the portal vein well.
5. Method B: (stop bleeding with fat pad, Figure 1C)17
- Expose the portal vein thoroughly.
- Use two cotton tips to hold the exposed portal vein from both the left and the right sides.
- Identify the fat tissue pad between the duodenum and the portal vein.
- Penetrate through the fat pad before inserting the needle into the portal vein (Figure 1D).
- Infuse the islets, following the similar procedure described above in part 4.2.1 and 4.2.2 of Method A.
- Pull out the needle while pressing down on the fat with a cotton tip.
- Continue pressing on the fat pad for 1 min after removing the needle.
- After confirming that there is no bleeding from the portal vein, gently return the intestine to the peritoneal cavity in its original position.
- Leave 0.5 mL of warm saline (36-37 °C) in the abdominal cavity before closure.
NOTE: Warm saline facilitates post-surgery intestine movement and recovery and prevents intestine necrosis. - Close the muscle layer with an 5-0 suture.
- Close the skin layer with an 4-0 suture.
- Place the mouse in a clean cage on a heating pad until fully recovered from anesthesia.
- Continue to provide an analgesic (e.g., buprenorphine 0.1 mg/kg i.p.) every 12 h and supplemental heat for 48 h post-surgery.
NOTE: The islet transplantation procedure takes approximately 15-20 min to complete.
6. H&E staining and photograph of whole liver section
- Liver perfusion
- Put the mouse under anesthesia as described above in part 3.1.
- Carefully expose the portal vein and cut the inferior vena cava.
- Manually perfuse the liver using 20 mL of 10% paraformaldehyde via the portal vein for about 5 minutes, using a 20 mL syringe with 25G needle18.
NOTE: Liver perfusion can remove blood from liver tissue and improve liver fixation without disturbing the islet grafts. - Dissect the perfused whole liver from other organs.
- Fix the perfused liver tissue in 10% paraformaldehyde for 24 h.
- Embed the tissue in paraffin.
- Cut tissue sections of 5 µm thickness each and put them on a glass slide for staining.
- Perform H&E, insulin, fibrin, and polymorphonuclear neutrophil (PMN) staining using standard methods15,16.
- Scan whole liver section under a microscope.
Subscription Required. Please recommend JoVE to your librarian.
Representative Results
We performed syngeneic and xenogeneic islet transplantations via the portal vein. Islet graft function was observed in a dose-dependent manner in both islet transplantation models. In the syngeneic islet transplantation model using C57BL/6 mice, transplantation of 250 islets led to transitory normoglycemia before mice returned to hyperglycemia. Mice receiving 500 islets reached and maintained normoglycemia beyond 30 days after transplantation (Figure 2A). Mice in both groups showed increased body weights (Figure 2B).
Similarly, in the human islets to diabetic NOD-SCID mouse islet transplantation model, islet graft function was compared when 45, 85, or 140 IEQs/kg of body weights were transplanted. Normoglycemia could not be achieved when 45 IEQ/g (~225-275 islets/mouse) human islets were transplanted. When the islet number increased to 85 IEQ/g (~ 400-450 islets/mouse), 35.7% (10/28) of the recipients achieved normoglycemia (p =0.02 vs. 45 IEQ/g group) at day 60 post-transplantation. Furthermore, 83.3% (5/6) of the recipients who received 140 IEQ/g (~ 600-650 islets/mouse) of human islets reached normoglycemia (Figure 2C). In addition, majority mice who had bleeding died after surgery while mice without bleeding survived (Figure 2D).
Once enough human islets are engrafted to NOD-SCID recipients, their blood glucose levels can be well-controlled at the early-stage post-transplantation and well-maintained until the end of the study. The grafted islets can be easily identified by H&E and insulin staining. At 28 days post-transplantation, transplanted human islets were distributed evenly throughout the whole liver, mostly around/close to a blood vessel (Figure 3).
The intrahepatic model was used to demonstrate instant blood mediated inflammatory reaction as seen in human islet transplantation. In our tissue section, we observed expression of insulin, and presence of fibrin and Polymorphonuclear leukocytes infiltration in transplanted islets (Figure 4A-D).
Figure 1: Illustration of intrahepatic islet transplantation procedures. (A, C). Schematics of key steps used in Method A and Method B. (B, D). Islets were injected directly via the portal vein (C) or indirectly via fat pat (D). Please click here to view a larger version of this figure.
Figure 2: Representative outcomes of intraportal islet transplantation. (A, B). Syngeneic mouse islet intraportal transplantation. Pancreatic islets (250 or 500) from C57BL/6 mice were transplanted into male C57BL/6 mice that were rendered diabetic by STZ. (A) Serial blood glucose levels were measured. Normoglycemia was defined as glucose levels <200 mg/dL for >2 consecutive days. (B) Increase in the recipients' body weight was observed post islet transplantation. (C) Percentage of diabetic NOD-SCID mice reaching normoglycemia in mice receiving a different number of human islets at 45 IEQ/g (n=7), 85 IEQ/g (n=28), and 140 IEQ/g (n=6). (D) Percentage of survival after IIT in bleeding and non-bleeding mice (n=14 each). Please click here to view a larger version of this figure.
Figure 3: H&E staining of liver sections of NOD-SCID liver bearing human islet graft at 28 days post-transplantation. Islets are marked by black circles. The diameter of each circle positively corresponds with the size of each islet. Scale bar =1,000 μm in whole liver section and 100 μm in inset. Please click here to view a larger version of this figure.
Figure 4: Representative histological pictures of intraportal transplanted mouse islets in liver 6 h after intraportal transplantation. (A) H&E, (B) insulin (red) (C) Fibrin, and (D) PMN stains. Scale bar = 100 μm. Please click here to view a larger version of this figure.
Subscription Required. Please recommend JoVE to your librarian.
Discussion
In this study, two improved procedures that can prevent bleeding and may reduce mouse mortality during mouse IIT have been demonstrated. This study enables researchers to visualize the islet transplantation model that is unique in studying the instant blood mediated inflammatory response after transplantation. The IIT model is a distinctive model for studying islet cell survival and hepatic ischemic injuries in response to islet transplantation19. Here, we refined the procedure based on previous studies and reduced early complication-induced mouse mortality. Both method A14,15,16 and method B8,9 were used in multiple studies. We showed that islets distributed among the whole liver, and neutrophil infiltration and thrombosis typically associated with IIT were prominent in graft immediately after transplantation.
There are several key steps in mouse hepatic islet transplantation. Because both human and mouse islets can be as large as 200 μm in size, a needle size of at least 27G must be used for transplantation to ensure the islet products' smooth flow. However, this would generate a large hole in the portal vein that may cause bleeding after needle removal. By injecting islets via the correct angle and using a dental sponge to block the injection site or injection through the fat tissue, the chance of bleeding can be minimized, and mice have higher survival rates after transplantation. These steps may also help avoid liver warm ischemia-reperfusion injuries caused by blockage of portal vein blood flow when performing this procedure19. They can also reduce the damages to the liver and the intestines that may contribute to mouse mortality post-surgery.
There are also several limitations of the mouse intrahepatic islet transplantation model compared to the human islet transplantations setting. First, we cannot monitor mouse portal vein pressure during islet infusion as we do in clinic settings. Second, the volume that can be transplanted into the mice may not reflect the high amount of islet product transplanted into a human. Therefore, the extent of thrombosis may be different. Thirdly, mouse islet grafts after transplantation will be temporarily exposed to a hyperglycemic environment since no insulin will be given to mice, while in humans20, insulin would be given during the peri-transplantation period to reduce the stress of transplanted islets20. Nevertheless, the intrahepatic islet model offers a unique pre-clinical model that can be used to study human islet transplantation.
Subscription Required. Please recommend JoVE to your librarian.
Disclosures
All authors declare that they do not have conflict of interest.
Acknowledgments
This study was supported by the Department of Veterans Affairs (VA-ORD BLR&D Merit I01BX004536), and the National Institute of Health grants # 1R01DK105183, DK120394, DK118529, to HW. We would like to thank you Mr. Michael Lee and Ms. Lindsay Swaby for language editing
Materials
| Name | Company | Catalog Number | Comments |
| 10% Neutral buffered formalin v/v | Fisher Scientific | 23426796 | |
| 1 mL Syringe with needle | AHS | AH01T | |
| 20 mL Syringe | BD | 301031 | |
| 25G x 5/8" hypodermic needles | BD | 305122 | |
| Alcohol prep pads, sterile | Fisher Scientific | 22-363-750 | |
| Animal Anesthesia system | VetEquip, Inc. | 901806 | |
| Buprenorphine hydrochloride, injection | Par Sterile Products, LLC | NDC 42023-179-05 | |
| Centrifuge tubes, 15 mL | Fisher Scientific | 0553859A | |
| CMRL-1066 | Corning | 15110CV | |
| DMEM | Corning | 10013CV | |
| Ethanol, absolute (200 proof), molecular biology grade | Fisher Scientific | BP2818500 | |
| Extra fine Micro Dissecting scissors 4” straight sharp | Roboz Surgical Instrument Co. | RS-5882 | |
| Fetal bovine serum (FBS) | Corning | 35011CV | |
| FreeStyle Glucose meter | Abbott | Lite | |
| FreeStyle Blood Glucose test strips | Abbott | Lite | |
| Gelfoam (absorbable gelatin sponge, USP) | Pharmacia & Upjohn Company | 34201 | |
| Graefe forceps 4” extra delicate tip | Roboz Surgical Instrument Co. | RS-5136 | |
| Heated pad | Amazon | B07HMKMBKM | |
| Hegar-Baumgartner Needle Holder 5.25” | Roboz Surgical Instrument Co. | RS-7850 | |
| Insulin syringe with 27-gauge needle | BD | 879588 | |
| Iodine prep pads | Fisher Scientific | 19-027048 | |
| Isoflurane | Piramal Critical Care | NDC 66794-017-25 | |
| Penicillin/streptomycin (P/S) | HyClone | SV30010 | |
| Polypropylene Suture 4-0 | Med-Vet International | MV-8683 | |
| Polypropylene Suture 5-0 | Med-Vet International | MV-8661 | |
| Sodium chloride, 0.9% intravenous solution | VWR | 2B1322Q | |
| Streptozocin (STZ) | Sigma | S0130 | |
| Surgical drape, sterile | Med-Vet International | DR1826 | |
| Tissue Cassette | Fisher Scientific | 22-272416 |
References
- Pellegrini, S., Cantarelli, E., Sordi, V., Nano, R., Piemonti, L. The state of the art of islet transplantation and cell therapy in type 1 diabetes. Acta Diabetology. 53 (5), 683-691 (2016).
- Ballinger, W. F., Lacy, P. E. Transplantation of intact pancreatic islets in rats. Surgery. 72 (2), 175-186 (1972).
- Wright, J. R., Hauptfeld, V., Lacy, P. E., et al. Induction of Ia antigen expression on murine islet parenchymal cells does not diminish islet allograft survival. American Journal of Pathology. 134 (2), 237-242 (1989).
- Toyofuku, A., et al. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes. 55 (1), 34-39 (2006).
- Goss, J. A., Nakafusa, Y., Finke, E. H., Flye, M. W., Lacy, P. E. Induction of tolerance to islet xenografts in a concordant rat-to-mouse model. Diabetes. 43 (1), 16-23 (1994).
- Hara, M., et al. A mouse model for studying intrahepatic islet transplantation. Transplantation. 78 (4), 615-618 (2004).
- Shapiro, A. M., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New England Journal of Medicine. 343 (4), 230-238 (2000).
- Wang, J., et al. Alpha-1 antitrypsin enhances islet engraftment by suppression of instant blood-mediated inflammatory reaction. Diabetes. 66 (4), 970-980 (2017).
- Gou, W., et al. Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation. American Journal of Transplantation. , (2020).
- Contreras, J. L., et al. Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes. 53 (11), 2804-2814 (2004).
- Moberg, L., et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 360 (9350), 2039-2045 (2002).
- Melzi, R., et al. Intrahepatic islet transplant in the mouse: functional and morphological characterization. Cell Transplantation. 17 (12), 1361-1370 (2008).
- Wang, H., et al. Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes. 54 (5), 1400-1406 (2005).
- Desai, C. S., et al. Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation. Islets. 9 (6), 140-149 (2017).
- Cui, W., Angsana, J., Wen, J., Chaikof, E. L. Liposomal formulations of thrombomodulin increase engraftment after intraportal islet transplantation. Cell Transplantation. 19 (11), 1359-1367 (2010).
- Cui, W., et al. Thrombomodulin improves early outcomes after intraportal islet transplantation. American Journal of Transplantation. 9 (6), 1308-1316 (2009).
- Proto, C., Grasso, G., Fassio, P. G. Hepatoparenchymal clearance of indocyanine green in infectious hepatitis. Giornale di Malattie Infettive e Parassitarie. 20 (9), 845-851 (1968).
- Cabral, F., et al. Purification of hepatocytes and sinusoidal endothelial cells from mouse liver perfusion. Journal of Visualized Experiments. (132), e56993 (2018).
- Khatri, R., Hussmann, B., Rawat, D., Gurol, A. O., Linn, T. Intraportal transplantation of pancreatic islets in mouse model. Journal of Visualized Experiments. (135), e57559 (2018).
- Wang, H., et al. Autologous mesenchymal stem cell and islet cotransplantation: Safety and efficacy. Stem Cells Translational Medicine. 7 (1), 11-19 (2018).
